(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

PIRIDAZINONA URÉIAS COMO ANTAGONISTAS DE INTEGRINAS ALFA4

ArquivadaInvention PatentPCT · US2005004181

Application data

Number

PI0506676

Type

Invention Patent

Filing

02/09/2005

Publication

05/15/2007

PCT

US2005004181

Progress at the INPI

  1. Filing02/09/05
  2. Publication05/15/07
  3. Abandoned
  4. Allowance
  5. Grant
  6. In force

The application was abandoned: examination was not requested within the 36 months following the 02/09/2005 filing, the deadline set by art. 33 of the Brazilian IP Act. The technology is in the public domain in Brazil.

Talk to a specialist

Latest action published by the INPI: 05/25/2010. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

Janssen Phamaceutica N.V.

BE

See this company's full portfolio

Inventors

K. B. (pessoa física)

US

W. H. (pessoa física)

US

Y. G. (pessoa física)

US

Technical data

Priority claims

US

60/543,315 · 02/10/2004

Abstract

PIRIDAZINONA URÉIAS COMO ANTAGONISTAS DE INTEGRINAS ALFA4. A presente invenção refere-se a compostos de fórmula (I), métodos para preparar estes compostos, composições, intermediários e derivados dos mesmos e para o tratamento de distúrbios mediados pela integrina 4. Mais particularmente, os compostos de piridazinona uréia da presente invenção são inibidores da integra 4 7 úteis para tratar distúrbios mediados por integrinas.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Arquivamento definitivo - Art. 33 da LPI

#11.1.1

05/25/2010

RPI 2055

Arquivamento - Art. 33 da LPI

#11.1

12/15/2009

RPI 2032

Notificação de entrada na fase nacional - PCT

#1.3

05/15/2007

RPI 1897

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.